Thus, although manipulating the Tim-3 immune checkpoint on NK cells may appear promising to restore NK-cell mediated immune surveillance in cancer, further studies are warranted to better decipher Tim-3 effects in human NK cells. This evidence concerns the gene HAVCR2 and cancer.